The Swiss pharmaceutical giant's plant will produce compounds needed for radioligand therapy (RLT), a form of precision ...

Swiss drugmaker Novartis said on Monday it has opened a new 10,000-square-foot factory in Carlsbad, California, to make ...

Novartis invests $23B in U.S. infrastructure, opening a new Carlsbad facility and expanding radioligand therapy sites. Read ...

Carlsbad location is company’s third US-based radioligand therapy (RLT) manufacturing site New site expands manufacturing footprint to meet ...

Novartis opens new radioligand therapy manufacturing facility in California as part of $23 billion US expansion plan: Basel Wednesday, November 12, 2025, 10:00 Hrs [IST] Novartis, ...

Novartis, a global innovative medicines company, has opened a new 10,000-square-foot radioligand therapy (RLT) manufacturing facility in Carlsbad, CA.

Novartis' blockbuster heart treatment Entresto saw sales growth stall in the third quarter, dragging the Swiss company's shares lower, as its top-selling drug comes under pressure from cheaper ...

Secondary endpoints “indicate symptom reduction and patient benefit beyond improvement in disease activity,” according to ...

"Novartis opens California site for RLT manufacturing" was originally created and published by Pharmaceutical Technology, a ...

While investment has slowed in radiopharmaceuticals, analysts predict increased interest to come as Novartis shows just how successful radiopharmaceuticals can be.

Late-breaking Phase III data show ianalumab, Novartis’ dual-targeted antibody, reduced disease activity and patient burden in ...

The drugmaker reported third-quarter profit of $3.93 billion after higher sales for key drugs allowed it to offset a hit from ...